MLB: White Sox sign RHP Mike Clevinger to one-year deal

Date:

Share post:


Right-hander Mike Clevinger agreed to terms with the Chicago White Sox on a one-year, $12 million contract Sunday.

Per the White Sox, Clevinger will receive $8 million in 2023 with a mutual $12 million option for 2024 that includes a $4 million buyout.

Clevinger, who turns 32 later this month, went 7-7 with a 4.33 ERA in 23 appearances (22 starts) for the San Diego Padres last season.

The former fourth-round draft pick by the Los Angeles Angels in 2011 spent his first 4 1/2 seasons in Cleveland before his young career hit a snag. He was moved to the Padres at the 2020 trade deadline after he had been suspended for violating team COVID-19 protocol.

Clevinger then pitched just four games with the Padres in 2020 before he needed Tommy John surgery, forcing him to miss the entire 2021 campaign.

In 128 career appearances (114 starts), Clevinger has gone 51-30 with a 3.39 ERA and 694 strikeouts over 656 2/3 innings.

The White Sox were projected to be a World Series contender last season but missed the playoffs with an 81-81 record. Manager Tony La Russa left the team for health considerations on Aug. 31 and did not return. Pedro Grifol was hired as manager on Nov. 1.

–Field Level Media

spot_img

Related articles

MLB: Luis Gil, Juan Soto carry Yankees past White Sox

Luis Gil struck out a career-high 14 batters, Juan Soto went 4-for-4 with two home runs, and the...

MLB: Twins activate OF Byron Buxton from IL

The Minnesota Twins activated outfielder Byron Buxton from the 10-day injured list on Saturday. In a corresponding move, the...

MLB: Rays acquire LHP Richard Lovelady from Cubs

The Tampa Bay Rays acquired Richard Lovelady from the Chicago Cubs on Saturday in exchange for fellow left-handed...

MLB: Orioles activate RHP Grayson Rodriguez to start vs. Mariners

The Baltimore Orioles activated right-hander Grayson Rodriguez from the 15-day injured list to start Saturday's game against the...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.